Drugs in R&D (@DrugsInRD) profile picture

Drugs in R&D, an international, Medline-Indexed, peer reviewed, #OpenAccess, online journal, focusing on #pharmacology

New Zealand
Joined June 2010
The political theatre of the UK's travel ban on South Africa thelancet.com/journals/lance…
We're celebrating the 50th birthday of our flagship Adis Premier journal @DrugsJournal (I.F. 9.546)! Publishing definitive #research and #reviews for healthcare professionals; plain language summaries and digital features are now available to maximise readership engagement.
1
2
5
This article has been making an impact with plenty citations since publication: Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells #SARSCoV2 #peptide rdcu.be/ck0Pw
Our latest publication: Population Pharmacokinetic Analysis of Rivipansel in Healthy Subjects and Subjects with Sickle Cell Disease #sickleCell #rivipansel rdcu.be/ck0Pr
Dosing considerations for Antibodies against COVID-19 rdcu.be/cgxOh #COVID19
Great review just published on repurposed COVID-19 Medications: rdcu.be/cgxN8 #COVID
Our latest review article looks at re-purposing of fingolimod for other neurologic disorders #fingolimid #neurology link.springer.com/content/pd…
Exciting #news for Oncology and Therapy... The journal is now indexed on #PubMed All articles from and including June 2018 are now indexed on the site: buff.ly/2OS26lA #cancer #oncology #openaccess
1
22
7
27
Our latest Review Article: Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor: link.springer.com/content/pd… #tenosynovial #pexidartinib
Malaria continues to be a public health concern. This nice study from Mali shows ex-vivo sensitivity of Plasmodium falciparum to common anti-malarial drugs. rdcu.be/b457a
In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection rdcu.be/b4Zi0
Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers rdcu.be/b4ZhQ
Rational use of hydroxychloroquine in COVID-19, based on existing Pharmacokinetic data rdcu.be/b3EEW
Another interesting article on this controversial topic: Extrapolation of Drug Clearance in Children ≤2 Years of Age from Empirical Models Using Data from Children (>2 Years) and Adults link.springer.com/content/pd…